SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH

 SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH contact information is shown below
Owner:SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH
Owner Address:HAMMERSTRASSE 25 4410 LIESTAL Switzerland
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned bySANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH

Brand:

CARDIBENONE

Description:

PHARMACEUTICAL, VETERINARY AND SANITARY PREPARATIONS, NAMELY, CHEMICAL PRODUCTS FOR USE IN THE FIELDS OF MUSCULAR DYSTROPHY, MUSCLE WASTING, ATROPHY, NEUROMUSCULAR DISEASES, CARDIOMYOPATHIES, ATAXIAS, OPTIC NERVE DEGRADATION, NEUROLOGICAL INDICATIONS AND MEMORY LOSS;CHEMICALS USED IN INDUSTRY AND SCIENCE;COMPUTER PROGRAMMING FOR SCIENTIFIC AND INDUSTRIAL RESEARCH IN THE FIELDS OF CELL CULTURES, MUSCULAR DYSTROPHY, MUSCLE WASTING, ATROPHY, NEUROMUSCULAR DISEASES, CARDIOMYOPATHIES, ATAXIAS, OPTIC NERVE DEGRADATION, NEUROLOGICAL INDICATIONS AND MEMORY LOSS; SCIENTIFIC RESEARCH FOR CELLULAR TEST SYSTEMS THAT EVALUATE DRUGS AND ANTIBODIES; SCIENTIFIC RESEARCH FOR FINDING PHARMACOLOGICALLY ACTIVE COMPOUNDS AND ANIMAL MODELS FOR NEUROMUSCULAR DISEASES; SCIENTIFIC RESEARCH IN THE FIELDS OF MUSCULAR DYSTROPHY, MUSCLE WASTING, ATROPHY, NEUROMUSCULAR DISEASES, CARDIOMYOPATHIES, ATAXIAS, OPTIC NERVE DEGRADATION, NEUROLOGICAL INDICATIONS AND MEMORY LOSS;

Category: PHARMACEUTICAL
Brand:

MYOBENONE

Description:

Pharmaceutical, veterinary and sanitary preparations, namely, chemical products for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss;MYOCONTRACT BE NONE;Chemicals for use in industry and science;Computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific research for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases; scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss;

Category: PHARMACEUTICAL